Adar1 Capital Management, LLC Anavex Life Sciences Corp. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 16,221 shares of AVXL stock, worth $135,769. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,221
Previous 16,221
-0.0%
Holding current value
$135,769
Previous $174 Million
20.11%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
202Shares Held
30.9MCall Options Held
1.3MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$53.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.9MShares$41 Million0.0% of portfolio
-
State Street Corp Boston, MA3.21MShares$26.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$16.4 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1MShares$8.37 Million0.77% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $652M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...